the importance of diagnosing dlbcl on a molecular level and how it will improve treatment
Published 7 years ago • 89 plays • Length 0:37Download video MP4
Download video MP3
Similar videos
-
3:04
applying molecular understanding of dlbcl to management strategies
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
4:46
current treatment options for older patients with dlbcl
-
5:02
treatment of lymphoma: overview of the continued progress
-
1:21
improving mrd assessment and response criteria in dlbcl: insights into phased-seq
-
5:30
how the treatment landscape of dlbcl is changing: r-chop vs pola-r-chp
-
1:26
can we improve on r-chop for the frontline treatment of dlbcl?
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
12:05
how to clean/change biobase hematology valves
-
29:38
dlbcl treatment approaches: what you need to know
-
46:42
imaging and radiation lunch & learn | wilmot cancer institute
-
1:08
the importance of recgonizing different dlbcl subtypes
-
1:21
novel approaches to harnessing the immune system in lymphoma
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
1:24
mm-6 study: in-class transition to a regimen of ixazomib, lenalidomide, & dexamethasone for myeloma
-
14:25
an overview of novel innovative treatments for patients with von willebrand disease
-
8:01
novel diagnostics & biomarkers for dlbcl and ctcl
-
1:34
molecular-guided treatment of b-cell lymphomas
-
3:58
phase ib/iia study of azd4573 acalabrutinib in r/r dlbcl
-
0:42
targeted therapies for dlbcl treatment
-
2:44
data on new therapeutic strategies in hodgkin lymphoma
-
0:54
the role of cd4 t-cells in the pathogenesis of hodgkin lymphoma